top of page
Search


Research Update: LMNA
We are honored to support groundbreaking discoveries related to LMNA-CMD.
Gustavo Dziewczapolski, Scientific Director
Sep 24, 20245 min read


Research Update: Dystroglycanopathy
We are honored to support groundbreaking discoveries related to Dystroglycanopathy.
Gustavo Dziewczapolski, Scientific Director
Aug 7, 20243 min read

Research Update: LAMA2
We are honored to support groundbreaking discoveries related to LAMA2-Related Dystrophy.
Gustavo Dziewczapolski, Scientific Director
Jul 2, 20244 min read


iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies
The MAGIC research team welcomes iMM to the consortium to add a cellular perspective to muscle-on-chip technologies
Gustavo Dziewczapolski, Scientific Director
Jun 6, 20242 min read

Research Update: SELENON
We are honored to support groundbreaking discoveries related to SELENON-Related Disorders.
Gustavo Dziewczapolski, Scientific Director
May 29, 20244 min read


Interview with Gustavo Dziewczapolski: Doctor in Neuropharmacology and Scientific Director of Cure CMD
Explore an in-depth interview with Gustavo Dziewczapolski, Doctor in Neuropharmacology and Scientific Director of Cure CMD. Gain insights in
Giulia Da Re
May 23, 202418 min read

2024 Myology Congress Recap
Cure CMD’s Scientific Director, Dr. Gustavo Dziewczapolski, provides a recap of his attendance at the 8th International Myology Congress in
Gustavo Dziewczapolski, Scientific Director
May 1, 20242 min read


Research Update: Collagen 6
We are honored to support groundbreaking discoveries in Collagen 6-Related Dystrophies (COL6-RD).
Gustavo Dziewczapolski, Scientific Director
Apr 16, 20244 min read

2019 SciFam Lay Summary: Stronger Together
A “Triad” of patient advocacy organizations for ultra-rare congenital muscular diseases, Cure CMD (Congenital Muscular Dystrophy), A...
Cure CMD
Nov 12, 20196 min read


Cure CMD's 5-Year Research Goals
Cure CMD has achieved significant impact in its first nine years as the only nonprofit organization in the U.S. dedicated specifically to...
Cure CMD
Nov 10, 20171 min read


2017 Kicks Off with New Treatments for Pediatric Neuromuscular Disorders
The last week of December 2016 finds us with the first and second ever FDA-approved treatments for two groups of affected individuals...
Cure CMD
Jan 8, 20173 min read


Introducing Cure CMD's new Scientific Director
Dear CMD Community, I am delighted to join Cure CMD as the new Scientific Director. I am eager to build on the legacy of strong...
Cure CMD
Oct 1, 20161 min read
bottom of page